IgG1-3 MuSK Antibodies Inhibit AChR Cluster Formation, Restored by SHP2 Inhibitor, Despite Normal MuSK, DOK7, or AChR Subunit Phosphorylation.
Cao M. et al, (2023), Neurol Neuroimmunol Neuroinflamm, 10
Motor end-plate analysis to diagnose immune-mediated myasthenia gravis in seronegative patients.
Nagaoka A. et al, (2022), J Neurol Sci, 443
Acute seizure risk in patients with encephalitis: development and validation of clinical prediction models from two independent prospective multicentre cohorts
Wood GK. et al, (2022), BMJ Neurology Open, 4, e000323 - e000323
Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis
Damato V. et al, (2022), Journal of Neurology, Neurosurgery & Psychiatry, 93, 995 - 1000
Inhibition of Maternal-to-Fetal Transfer of IgG Antibodies by FcRn Blockade in a Mouse Model of Arthrogryposis Multiplex Congenita.
Coutinho E. et al, (2021), Neurol Neuroimmunol Neuroinflamm, 8
Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis
Pollak TA. et al, (2021), Molecular Psychiatry, 26, 2590 - 2604
Using AChR antibody titres to predict treatment responses in myasthenia gravis.
Vincent A., (2021), J Neurol Neurosurg Psychiatry
Neuronal surface antibodies are common in children with narcolepsy and active movement disorders.
Giannoccaro MP. et al, (2020), J Neurol Neurosurg Psychiatry
Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs.
Cetin H. et al, (2020), J Neurol Neurosurg Psychiatry, 91, 526 - 532
SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody.
Huda S. et al, (2020), Neurol Neuroimmunol Neuroinflamm, 7
Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia
Vincent A. et al, (2018), JAMA Neurology, 75, 1519 - 1519
Investigation of neuronal auto-antibodies in children diagnosed with epileptic encephalopathy of unknown cause
Tekturk P. et al, (2018), Brain and Development, 40, 909 - 917
Plasma cell depletion with bortezomib in the treatment of refractory N -methyl-d -aspartate (NMDA) receptor antibody encephalitis. Rational developments in neuroimmunological treatment
Keddie S. et al, (2018), European Journal of Neurology, 25, 1384 - 1388
NMDA-receptor antibodies alter cortical microcircuit dynamics
Rosch RE. et al, (2018), Proceedings of the National Academy of Sciences, 115, E9916 - E9925
Antiglycine receptor antibody related disease: a case series and literature review
Swayne A. et al, (2018), European Journal of Neurology, 25, 1290 - 1298
SHP2 INHIBITION BY NSC-87877 RECOVERS THE PATHOGENIC IN VITRO EFFECTS OF MUSK-MG ANTIBODY SUBCLASSES
Cao M. et al, (2018), MUSCLE & NERVE, 58, S15 - S16
Glutamate receptor δ2 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome
Berridge G. et al, (2018), Neurology, 91
Brain-relevant antibodies in first-episode psychosis: a matched case–control study
Gaughran F. et al, (2018), Psychological Medicine, 48, 1257 - 1263
Pathogenic Mechanisms and Clinical Correlations in Autoimmune Myasthenic Syndromes
Cetin H. and Vincent A., (2018), Seminars in Neurology, 38, 344 - 354